Kyverna Therapeutics, Inc. · NASDAQ:KYTX
Kyverna Therapeutics, Inc. shareholders
As of Jun 30, 2026, 114 institutions reported holding Kyverna Therapeutics, Inc., 60.8% of its shares. Largest: GordonMD Global Investments LP, Gilead Sciences, Inc. and BlackRock. New holders, exits, insiders and big stakes, each with its filing.
| Holder | Shares | % of Kyverna Therapeutics, Inc. | Change | Filed |
|---|---|---|---|---|
| GordonMD Global Investments LP | 4.24M | 6.9% | no change | Aug 14, 2026 |
| Gilead Sciences, Inc. | 4.13M | 6.7% | no change | Aug 3, 2026 |
| BlackRock | 3.13M | 5.1% | +2.26M | Aug 7, 2026 |
| Bain Capital Life Sciences Investors, LLC | 2.88M | 4.7% | −225K | Aug 14, 2026 |
| AIGH Capital Management LLC | 2.8M | 4.5% | +796K | Aug 7, 2026 |
| Vanguard | 2.47M | 4.0% | +431K | Aug 13, 2026 |
| Deerfield Management Company, L.P. | 2M | 3.2% | no change | Aug 14, 2026 |
| T. Rowe Price | 1.19M | 1.9% | −369K | Aug 14, 2026 |
| Geode Capital | 1.05M | 1.7% | +626K | Aug 12, 2026 |
| Insight Holdings Group, LLC | 989K | 1.6% | no change | Aug 14, 2026 |